2nd World Congress on Rare Diseases and Orphan Drugs June 29-30, 2017 London, UK

Nadia Ameen completed her medical degree from the University of the West Indies, Jamaica. She completed training in Pediatrics at Children’s Hospital Wisconsin and then pursued post-doctoral fellowship in gastroenterology at Yale University School of Medicine. She is the principal investigator of an NIH supported research laboratory at Yale University that studies CFTR and diarrheal diseases for over 20 years. She was the first to recognize a trafficking defect in MVID before a genetic defect was identified. She has authored more than 30 papers in reputed journals and serves as an editorial board member for several journals.

Intestinal Diseases

Deputy Chairman, Intensive Care Department, Consultant, Pulmonary and Critical Care Medicine, Professor, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia, Dr.AlDawood graduate from College of Medicine in Kingdom of Saudi Arabia. Then he completed the Residency in Internal Medicine Program in McMaster University in Canada He obtained Critical Care and Respirology Fellowship Program in McMaster University, Canada (Jul 97-Jun 00). In July 2000, he joined King Abdulaziz Medical City, Riyadh, Saudi Arabia as a Consultant in Critical Care and Pulmonary Medicine up to the present. He is currently the Deputy Chairman of the Intensive Care Department and Professor in King Saud Bin Abdulaziz University for Health Sciences. In addition, he has more than 40 publications including articles in the New England Journal of Medicine (NEJM), JAMA, American Journal of Respiratory Critical Care Medicine, BMC Anesthesiology, and Critical Care Medicine.

Respiratory Critical Care Medicine, Rare Diseases, BMC Anesthesiology,and Critical Care Medicine

Dr. Wei Zheng received his Ph.D. in Pharmacology from the State University of New York at Buffalo. He had worked 12 years in pharmaceutical companies (Berlex, Amgen, and Merck) for drug discovery and development. Since 2005, Dr. Zheng has worked at National Institutes of Health for development of therapeutics for rare and neglected diseases. He has identified several drugs from drug repurposing screens and advanced two of them to clinical trials. Currently, Dr. Zheng is working on the therapeutics development for lysosomal storage diseases, drug resistant cancer and infectious diseases.

Drug resistant, Infectious Diseases

Division of Bioinformatics and Biostatistics, FDA

Rare Diseases,chemoinformatics, Predictive toxicologyOrphan Drugs,

Professor Joseph Ndung’u is the Head of FIND’s Neglected Tropical Diseases (NTD) programme. He has a degree in veterinary medicine and surgery (BVM) from the University of Nairobi, and a PhD on the immunopathology of human African trypanosomiasis (HAT or sleeping sickness) from the University of Glasgow’s Veterinary School in Scotland. He became a Visiting Professor of the University in 2001, and has held a similar position at the University of Wisconsin, Madison, USA. In 2013, he became a Corresponding Fellow of the Royal Society of Edinburgh

Tropical Diseases